Eudaimonia Asset Management »

Celldex Therapeutics shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.9M 70k 41.97
2023-03-31 $4.8M 342k 13.99
2022-12-31 $2.5M 56k 44.57
2021-09-30 $4.7M 86k 53.99
2021-06-30 $1.7M 51k 33.44
2020-12-31 $1.8M 100k 17.52
2020-09-30 $2.1M 141k 14.83
2020-06-30 $899k 69k 13.01

More positions owned by Eudaimonia Asset Management

Super Micro Computer Common Stock (SMCI)
FTAI Aviation Common Stock (FIP)
Viking Therapeutics Common Stock (VKTX)
Applied Industrial Technologies Common Stock (AIT)
NEXTracker Common Stock (NXT)
Comfort Systems USA Common Stock (FIX)
Aaon Common Stock (AAON)
Leonardo SpA Common Stock (DRS)
Sweetgreen Common Stock (SG)
Dycom Industries Common Stock (DY)
Ryman Hospitality Properties Common Stock (RHP)
Installed Building Products Common Stock (IBP)
Crinetics Pharmaceuticals Common Stock (CRNX)
RxSight Common Stock (RXST)
Q2 Holdings Common Stock (QTWO)

View all positions for Eudaimonia Asset Management

Top funds holding Celldex Therapeutics

FMR
Wellington Management Company
BlackRock
Vanguard Group
Eventide Asset Management
T. Rowe Price Associates
Kynam Capital Management
Bellevue Group
Pictet Asset Management Holding SA
Geode Capital Management
Rock Springs Capital Management
Point72 Asset Management
Marshall Wace
Redmile Group
Commodore Capital

View all funds holding Celldex Therapeutics